Fresh analysis reveals that people who come off new weight-loss injections like semaglutide or tirzepatide tend to recover reduced body mass much more quickly than those who end traditional lifestyle programs.
Published data in a prominent medical journal points out that while overweight individuals often shed a large proportion of their total mass while undergoing treatment, the weight comes back at an estimated rate of 0.8 kg per month upon discontinuation.
"Users buying such treatments must be informed of the risk of quick weight regain when the medication ends," cautioned researcher Dr. Susan Jebb.
That rate of regain means a return to starting mass in about one and a half years.
Comparing Treatments
The study, which looked at dozens of trials involving over 9,000 of patients, contrasted the effects of these new drugs with older methods.
Researchers emphasize that individuals who shed pounds through dieting typically have a slower creep back—perhaps 100 grams monthly—after stopping.
Explaining the Quick Regain
Doctors believe the mechanism of the jabs is key to understanding the accelerated regain.
GLP-1 drugs mimic a body's own chemical called GLP-1, which controls hunger.
"Long-term administration of the hormone concentrations several times higher than the body's typical production may cause the system to generate a reduced amount of its own natural GLP-1, and could reduce responsiveness to its effects," explained Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this GLP-1 'fix' results in hunger is no longer kept in check, making excessive eating much more probable."
A Lifelong Condition?
Medical guidelines suggest the jabs for people with obesity-related medical conditions, alongside prescribed diet and exercise modifications.
Many experts contend that, due to the significant potential of relapse, the treatment should be considered long-term.
This perspective is reinforced by pharmaceutical companies, who note that the findings "emphasize the long-term nature of obesity," comparing it to managing conditions like high blood pressure.
Patient Testimonies
Individuals who have discontinued the jabs report a intense resurgence of cravings.
"It felt as if a trigger flipping and you're instantly extremely hungry," said an individual.
The struggle is exacerbated if users have not established lasting lifestyle or habit modifications during treatment.
Significant Adoption
Figures show that millions of people in the UK have tried these injections in the last 12 months, with interest continuing to grow.
- Adoption is greater among women compared to males.
- The middle-aged demographic shows the highest usage rates.
- Many access the drugs through private healthcare rather than the NHS.
In conclusion, researchers emphasize that while the jabs are potent tools for weight loss, they are not a magic cure and lasting health benefits relies on ongoing lifestyle support.
